NASDAQ: BCAX · Health Care / Biotechnology: Pharmaceutical Preparations

Bicara Therapeutics Inc.

How Bicara Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.1B

Price

$16.89

P/E

-6.0

EPS (TTM)

$-2.81

1-year return

2.7%

Dividend yield

0.0%

52-week range

$15.88–$18.61

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources